• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】58418

【品名】2-({[amino(imino)methyl]sulfanyl}methyl)-5-(tert-butyl)-1,3-oxazole

【CA登记号】345629-22-3

【 分 子 式 】C9H15N3OS

【 分 子 量 】213.30372

【元素组成】C 50.68% H 7.09% N 19.7% O 7.5% S 15.03%

与该中间体有关的原料药合成路线共 2 条

合成路线1

该中间体在本合成路线中的序号:(VII)

Treatment of 1-bromo-3,3-dimethyl-2-butanone (I) with hexamethylenetetraamine affords the quaternary salt (II), which is then hydrolyzed to amino ketone (III) under acidic conditions (1-3). Alternatively, reaction of butanone (I) with sodium azide in acetone gives the azido derivative (IV), which is reduced with H2 over Pd/C in methanol to yield 1-amino-3,3-dimethyl-2-butanone (III). Acylation of amine (III) with 2-chloroacetyl chloride by means of triethylamine in dichloromethane yields the chloroacetamide (V), which is cyclized in POCl3 at 105 ºC to provide 5-tert-butyl-2-(chloromethyl)oxazole (VI) (1-4). Condensation of chloride (VI) with thiourea gives the S-alkylated thiouronium salt (VII), which is then submitted to alkaline hydrolysis followed by condensation with 2-amino-5-bromothiazole (VIII) under phase-transfer conditions in the presence of tetrabutylammonium sulfate, leading to thioether (IX) (1-3). Acylation of aminothiazole (IX) with 1-Boc-piperidine-4-carboxylic acid (X) —obtained by reaction of piperidine-4-carboxylic acid (XI) with Boc2O and NaOH in dioxane/acetonitrile— by means of EDAC and DMAP in DMF/dichloromethane yields the carboxamide (XII), which is finally deprotected upon treatment with trifluoroacetic acid (1-3) or by means of HCl in hot dioxane/CHCl (4). Scheme 1.

1 Xiao, H.-Y., Misra, R.N. (Bristol-Myers Squibb Co.). N-[5-[[[5-Alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases. CA 2394552, EP1240166, JP 2003516987, WO 2001044242.
2 Xiao, H.-Y., Misra, R.N. (Bristol-Myers Squibb Co.). N-[5-[[[5-Alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases. CA 2417254, EP 1303513, JP 2004509857, WO 2002010162.
3 Kim, K.S., Kimball, D., Cai, Z.-W. et al. (Bristol-Myers Squibb Co.). Aminothiazole inhibitors of cyclin dependent kinases. US 6262096.
4 Misra, N.R., Xiao, H., Kim, K.S. et al. N-(Cycloalkylamino)acyl-2-aminothiazole inhibitors of cyclin-dependent kinase 2. N-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4-piperidinecarboxamide (BMS-387032), a highly efficacious and selective antitumor agent. J Med Chem 2004, 47(7): 1719-28.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 30809 1-bromo-3,3-dimethyl-2-butanone 5469-26-1 C6H11BrO 详情 详情
(II) 65780     C12H23BrN4O 详情 详情
(III) 58415 1-amino-3,3-dimethyl-2-butanone 82962-91-2 C6H13NO 详情 详情
(IV) 58414 1-azido-3,3-dimethyl-2-butanone 76779-98-1 C6H11N3O 详情 详情
(V) 58416 2-chloro-N-(3,3-dimethyl-2-oxobutyl)acetamide C8H14ClNO2 详情 详情
(VI) 58417 5-(tert-butyl)-2-(chloromethyl)-1,3-oxazole 224441-73-0 C8H12ClNO 详情 详情
(VII) 58418 2-({[amino(imino)methyl]sulfanyl}methyl)-5-(tert-butyl)-1,3-oxazole 345629-22-3 C9H15N3OS 详情 详情
(VIII) 65781 2-Amino-5-bromothiazole monohydrobromide; 5-Bromothiazol-2-amine monohydrobromide 61296-22-8 C3H3BrN2S.HBr 详情 详情
(IX) 58420 5-({[5-(tert-butyl)-1,3-oxazol-2-yl]methyl}sulfanyl)-1,3-thiazol-2-amine; 5-({[5-(tert-butyl)-1,3-oxazol-2-yl]methyl}sulfanyl)-1,3-thiazol-2-ylamine 224436-97-9 C11H15N3OS2 详情 详情
(X) 17404 1-(tert-butoxycarbonyl)-4-piperidinecarboxylic acid; 1-BOC-piperidine-4-carboxylic acid; N-Boc-isonipecotic acid 84358-13-4 C11H19NO4 详情 详情
(XI) 17402 4-nipecotic acid;piperidine-4-carboxylic acid;p-nipecotic acid; Isonipecotic acid; Hexahydroisonicotinic acid; 4-Piperidinecarboxylic acid 498-94-2 C6H11NO2 详情 详情
(XII) 65782 tert-Butyl 4-[[5-[[(5-tert-butyloxazol-2-yl)methyl]thio]thiazol-2-yl]carbamoyl]piperidine-1-carboxylate 345629-23-4 C22H32N4O4S2 详情 详情

合成路线2

该中间体在本合成路线中的序号:(VI)

Substitution of 1-bromo-3,3-dimethyl-2-butanone (I) with NaN3 affords the azido ketone (II), which is reduced to amino ketone (III) by either catalytic hydrogenation or with triphenylphosphine. Acylation of (III) with chloroacetyl chloride affords amide (IV). Cyclization of the keto amide (IV) in hot POCl3 or in the presence of Burgess' reagent leads to the chloromethyl oxazole (V). Displacement of the chlorine atom of (V) with thiourea provides the S-alkyl isothiourea (VI). Hydrolysis of (VI), followed by condensation with 2-amino-5-bromothiazole (VII) under phase-transfer conditions furnishes thioether (VIII). The amino thiazole (VIII) is then coupled with 4-(bromomethyl)phenylacetic acid (IX), yielding amide (X). Finally, the bromide group of (X) is displaced with 2-amino-1,3-propanediol (XI) to produce the title compound.

1 Kim, K.S.; Misra, R.N.; Hunt, J.T.; Kimball, S.D.; Poss, M.A.; Han, W.-C.; Webster, K.R.; Cai, Z.-W.; Rawlins, D.B. (Bristol-Myers Squibb Co.); N-[5-[[[5-Alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases. EP 1240165; WO 0144241 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 30809 1-bromo-3,3-dimethyl-2-butanone 5469-26-1 C6H11BrO 详情 详情
(II) 58414 1-azido-3,3-dimethyl-2-butanone 76779-98-1 C6H11N3O 详情 详情
(III) 58415 1-amino-3,3-dimethyl-2-butanone 82962-91-2 C6H13NO 详情 详情
(IV) 58416 2-chloro-N-(3,3-dimethyl-2-oxobutyl)acetamide C8H14ClNO2 详情 详情
(V) 58417 5-(tert-butyl)-2-(chloromethyl)-1,3-oxazole 224441-73-0 C8H12ClNO 详情 详情
(VI) 58418 2-({[amino(imino)methyl]sulfanyl}methyl)-5-(tert-butyl)-1,3-oxazole 345629-22-3 C9H15N3OS 详情 详情
(VII) 58419 5-bromo-1,3-thiazol-2-ylamine; 5-bromo-1,3-thiazol-2-amine C3H3BrN2S 详情 详情
(VIII) 58420 5-({[5-(tert-butyl)-1,3-oxazol-2-yl]methyl}sulfanyl)-1,3-thiazol-2-amine; 5-({[5-(tert-butyl)-1,3-oxazol-2-yl]methyl}sulfanyl)-1,3-thiazol-2-ylamine 224436-97-9 C11H15N3OS2 详情 详情
(IX) 58421 2-[4-(bromomethyl)phenyl]acetic acid; 4-(Bromomethyl)phenyl acetic acid; 4-Carboxymethylbenzyl bromide 13737-36-5 C9H9BrO2 详情 详情
(X) 58422 2-[4-(bromomethyl)phenyl]-N-[5-({[5-(tert-butyl)-1,3-oxazol-2-yl]methyl}sulfanyl)-1,3-thiazol-2-yl]acetamide C20H22BrN3O2S2 详情 详情
(XI) 23333 2-amino-1,3-propanediol; serinol 534-03-2 C3H9NO2 详情 详情
Extended Information